Clinigen Group PLC (LON:CLIN) said its international platform was taking shape to support higher organic growth as it said profits advanced by a third in the first half. Later it was revealed that finance chief Nick Keher had snapped up around £35,000 worth of the company’s shares at a price of 893p apiece.
The City Pub Group PLC (LON:CPC) has reported an almost 20% rise in profits for its first half as it shifted its focus toward developing its pub estate and improving dividends for investors.
hVIVO PLC (LON:HVO) said it is primed for profitability next year. The projection was made alongside interim results that revealed £11mln of costs have been extracted from clinical development services business since 2017.
Renewable power provider SIMEC Atlantis Energy Limited (LON:SAE) said it achieved its best-ever operating results at its MeyGen tidal power project. Revenue for the first six months of the year increased to £2mln from £1.3mln the year before, with the majority of the revenue coming from MeyGen power sales.
NetScientific PLC (LON:NSCI) shares bounced higher on Thursday after its portfolio firm, PDS Biotechnology, announced positive data from a Phase 1 trial of a treatment for human papillomavirus (HPV). The company said its general aim for the second half of its financial year was to realise more value from its investee companies.
Verona Pharma PLC (LON:VRP) will present positive interim data from a Phase 2 trial with its dry powder inhaler formulation of ensifentrine in chronic obstructive pulmonary disease at the European Respiratory Society International Congress a week on Sunday. As announced in March, the magnitude of improvement in lung function and duration of action were highly statistically significant and support twice daily dosing of ensifentrine for the treatment of COPD.
Adamas Finance Asia Ltd (LON:ADAM) improved cash income sharply in the first half and could begin paying a dividend soon, said broker Pello Capital as it began coverage of the pan-Asian diversified investment vehicle on Thursday. Analysts at Pello, one of the company’s two ‘house’ brokers, concluded: “With its share price at 30p – representing a 66% discount – the share price is already reflecting a number of risk factors we believe; such as disposal & reinvestment risk, relative illiquidity of the shares and the wide bid-offer spread, plus the possibility of fresh equity issuance.”
Seeing Machines Ltd (LON:SEE) chief executive Paul McGlone will present the company’s year end results presentation live via webcast on Tuesday 24 September, hosted by Proactive Investors and streamed via YouTube at https://youtu.be/W8GifWJYiKc.